Oral HPV16 Prevalence in Oral Potentially Malignant Disorders and Oral Cavity Cancers

Biomolecules. 2020 Feb 3;10(2):223. doi: 10.3390/biom10020223.

Abstract

The role of human papillomavirus type 16 (HPV16) in oral potentially malignant disorders (OPMD) and oral cavity carcinoma (OC) is still under debate. We investigated HPV16 prevalence in unstimulated saliva, oral rinse samples, oral swabs and tumour biopsies collected from OPMD (n = 83) and OC (n = 106) patients. HPV16 genotype, viral load, physical status (episomal vs. integrated) and tumour p16INK4a expression were determined. Oral HPV16 prevalence was higher in OC than in OPMD, but this difference was not statistically significant (7.5% (8/106) versus 3.6% (3/83), odds ratio (OR): 2.18, 95% confidence interval (CI): 0.56, 8.48, p = 0.26). There was a significant association (p < 0.05) between oral HPV16 infection and heavy tobacco consumption. Real-time PCR results indicated that no integration events occurred in either OPMD or OC cases based on the HPV16 E2/E6 ratio. HPV16 positive OPMD and OC patients had similar HPV16 E2 and E6 viral loads. The inter-rater agreement between tumour p16INK4a expression and oral HPV16 infection was considered as fair (k = 0.361) for OC. Our data suggest that the involvement of HPV16 in oral carcinogenesis is limited.

Keywords: human papillomavirus; oral cavity cancer; oral potentially malignant disorder; saliva; viral load and HPV integration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Australia / epidemiology
  • Biopsy
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics*
  • DNA, Viral
  • Female
  • Genotype
  • Human papillomavirus 16 / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mouth Neoplasms / epidemiology*
  • Mouth Neoplasms / virology*
  • Observer Variation
  • Odds Ratio
  • Papillomavirus Infections / epidemiology*
  • Prevalence
  • Real-Time Polymerase Chain Reaction
  • Saliva / virology
  • Smoking
  • Viral Load

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Viral